These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33221614)

  • 1. Legal cannabis market shares during Canada's first year of recreational legalisation.
    Armstrong MJ
    Int J Drug Policy; 2021 Feb; 88():103028. PubMed ID: 33221614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to legal cannabis market in Canada over the four years following non-medical cannabis legalisation.
    Myran DT; Friesen EL; Dickson S; Konikoff L; Arora G; Tanuseputro P
    Drug Alcohol Rev; 2023 Jul; 42(5):1114-1119. PubMed ID: 36933893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How has access to legal cannabis changed over time? An analysis of the cannabis retail market in Canada 2 years following the legalisation of recreational cannabis.
    Myran DT; Staykov E; Cantor N; Taljaard M; Quach BI; Hawken S; Tanuseputro P
    Drug Alcohol Rev; 2022 Feb; 41(2):377-385. PubMed ID: 34250645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships between increases in Canadian cannabis stores, sales, and prevalence.
    Armstrong MJ
    Drug Alcohol Depend; 2021 Nov; 228():109071. PubMed ID: 34592703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability, retail price and potency of legal and illegal cannabis in Canada after recreational cannabis legalisation.
    Mahamad S; Wadsworth E; Rynard V; Goodman S; Hammond D
    Drug Alcohol Rev; 2020 May; 39(4):337-346. PubMed ID: 32291811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in health harms due to cannabis following legalisation of non-medical cannabis in Canada in context of cannabis commercialisation: A scoping review.
    Myran DT; Imtiaz S; Konikoff L; Douglas L; Elton-Marshall T
    Drug Alcohol Rev; 2023 Feb; 42(2):277-298. PubMed ID: 36165188
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationships between sales of legal medical cannabis and alcohol in Canada
    Armstrong MJ
    Health Policy; 2023 Feb; 128():28-33. PubMed ID: 36443110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrupted time series analysis of Canadian legal cannabis sales during the COVID-19 pandemic.
    Armstrong MJ; Cantor N; Smith BT; Jesseman R; Hobin E; Myran DT
    Drug Alcohol Rev; 2022 Jul; 41(5):1131-1135. PubMed ID: 35316855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.
    Smart R; Caulkins JP; Kilmer B; Davenport S; Midgette G
    Addiction; 2017 Dec; 112(12):2167-2177. PubMed ID: 28556310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Big data on a big new market: Insights from Washington State's legal cannabis market.
    Caulkins JP; Bao Y; Davenport S; Fahli I; Guo Y; Kinnard K; Najewicz M; Renaud L; Kilmer B
    Int J Drug Policy; 2018 Jul; 57():86-94. PubMed ID: 29709847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Geographic clustering of cannabis stores in Canadian cities: A spatial analysis of the legal cannabis market 4 years post-legalisation.
    Friesen EL; Konikoff L; Dickson S; Myran DT
    Drug Alcohol Rev; 2024 Nov; 43(7):1753-1763. PubMed ID: 38803128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis Retail Market Indicators in Five Legal States in the United States: A Public Health Perspective.
    Dilley JA; Johnson JK; Colby AM; Sheehy TJ; Muse EJ; Filley JR; Segawa MB; Schauer GL; Kilmer B
    Clin Ther; 2023 Aug; 45(8):778-786. PubMed ID: 37455228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between recreational cannabis legalization, commercialization and cannabis-attributable emergency department visits in Ontario, Canada: an interrupted time-series analysis.
    Myran DT; Pugliese M; Tanuseputro P; Cantor N; Rhodes E; Taljaard M
    Addiction; 2022 Jul; 117(7):1952-1960. PubMed ID: 35170149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triangulating web & general population surveys: Do results match legal cannabis market sales?
    Caulkins JP; Davenport S; Doanvo A; Furlong K; Siddique A; Turner M; Kilmer B
    Int J Drug Policy; 2019 Nov; 73():293-300. PubMed ID: 31272752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Price and product variation in Washington's recreational cannabis market.
    Davenport S
    Int J Drug Policy; 2021 May; 91():102547. PubMed ID: 31522966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Canada's cannabis legalisation on youth emergency department visits for cannabis-related disorders and poisoning in Ontario and Alberta, 2015-2019.
    Callaghan RC; Sanches M; Vander Heiden J; Kish SJ
    Drug Alcohol Rev; 2023 Jul; 42(5):1104-1113. PubMed ID: 36908258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Out-of-state cannabis purchases in the United States.
    Wadsworth E; Hammond D
    Drug Alcohol Depend; 2020 Feb; 207():107822. PubMed ID: 31911336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Canada's Recreational Cannabis Legalization and Medical Cannabis Patient Activity, 2017-2022.
    Armstrong MJ
    Am J Public Health; 2024 Nov; 114(S8):S673-S680. PubMed ID: 39361903
    [No Abstract]   [Full Text] [Related]  

  • 19. Distribution of legal retail cannabis stores in Canada by neighbourhood deprivation.
    Fataar F; Driezen P; Owusu-Bempah A; Hammond D
    J Cannabis Res; 2024 Feb; 6(1):5. PubMed ID: 38351142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Social and public health implications of the legalisation of recreational cannabis: A literature review.
    Mokwena K
    Afr J Prim Health Care Fam Med; 2019 Nov; 11(1):e1-e6. PubMed ID: 31793317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.